Article
Role of key TYMS polymorphisms on methotrexate therapeutic outcome in portuguese rheumatoid arthritis patients.
PloS one - 1 Jan 2014
Lima Aurea, Seabra Vítor, Bernardes Miguel, Azevedo Rita, Sousa Hugo, Medeiros Rui
Abstract excerpt
BACKGROUND: Therapeutic outcome of rheumatoid arthritis (RA) patients treated with methotrexate (MTX) can be modulated by thymidylate synthase (TS) levels, which may be altered by genetic polymorphisms in TS gene (TYMS). This study aims to elucidate the influence of TYMS polymorphisms in MTX therapeutic outcome (regarding both clinical response and toxicity) in Portuguese RA patients. METHODS: Clinicopathological...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
